Adis JournalsBrowse

File(s) not publicly available

A Response To: Sodium-Glucose Cotransporter-2 Inhibitors and Major Covid-19 Outcomes: Promising Mechanisms, Conflicting Data And Intriguing Clinical Decisions

media
posted on 2020-10-13, 10:29 authored by Antonio C. Bossi, Franco Forloni, Paolo L. Colombelli

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

Usage metrics

Read the peer-reviewed publication

A Response To: Sodium-Glucose Cotransporter-2 Inhibitors and Major Covid-19 Outcomes: Promising Mechanisms, Conflicting Data And Intriguing Clinical Decisions
Diabetes TherapyDiabetes Therapy

Categories

Keywords

Pleiotropic effects of SGLT2-iSGLT2-i in COVID-19Sodium glucose cotransporter 2 inhibitors (SGLT2-i)

Licence

CC BY-NC 4.0

Exports